Lucid Diagnostics Insider Trades

LUCD

Track insider trading activity from Lucid Diagnostics executives and directors. See which insiders are buying and selling LUCD stock.

Trades Last 12 Months

LUCD Price

All Insider Trades for Lucid Diagnostics

Sort by: Latest Trade Biggest Holding
Insider
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Matheis Dennis Director
Holding Value $1.04M 1,033,443 shares
Last Trade
May 20, 2026 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$245k 245,000 shares
$1.00
$1.00
Lee Victoria Tou Ho Chief Medical Officer
Holding Value $0 0 shares
Last Trade
Mar 23, 2026 Sale
$125k 100,000 shares
$1.25
$1.00
Gordon Michael Adam General Counsel And Secretary
Holding Value $1.01M 1,000,000 shares
Last Trade
Feb 20, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$408k 300,000 shares
$1.36
$1.00
Lapidus Stanley Director
Holding Value $339k 337,392 shares
Last Trade
Feb 20, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$167k 123,000 shares
$1.36
$1.00
Aklog Lishan Chief Executive Officer
Holding Value $3.65M 3,636,627 shares
Last Trade
Feb 20, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$2.95M 2,170,000 shares
$1.36
$1.00
Cox James L Director
Holding Value $407k 405,120 shares
Last Trade
Feb 20, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$167k 123,000 shares
$1.36
$1.00
O'neil Shaun President And COO
Holding Value $1.45M 1,446,763 shares
Last Trade
Feb 20, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$843k 620,000 shares
$1.36
$1.00
Palumbo John R Director
Holding Value $340k 338,000 shares
Last Trade
Feb 20, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$167k 123,000 shares
$1.36
$1.00
Sokolov Jacque J Director
Holding Value $322k 320,460 shares
Last Trade
Feb 20, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$167k 123,000 shares
$1.36
$1.00
Sparks Ronald M Director
Holding Value $322k 320,460 shares
Last Trade
Feb 20, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$167k 123,000 shares
$1.36
$1.00
White Debra Director
Holding Value $237k 235,800 shares
Last Trade
Feb 20, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$167k 123,000 shares
$1.36
$1.00
Mcgrath Dennis M Chief Financial Officer
Holding Value $1.82M 1,813,569 shares
Last Trade
Feb 20, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$639k 470,000 shares
$1.36
$1.00
O'neil Shaun President And COO
Holding Value $831k 826,763 shares
Last Trade
Feb 20, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$447k 300,000 shares
$1.49
$1.00
Pavmed Inc. 10% owner
Holding Value $31.5M 31,302,444 shares
Last Trade
Feb 15, 2024 Sale (Other)Another type of insider transaction reported on SEC Form 4.
$4.56M 3,331,747 shares
$1.37
$1.00
Pa Vmed Inc. Director
Holding Value $40.9M 40,672,939 shares
Last Trade
Nov 30, 2022 Purchase (Other)Another type of insider transaction reported on SEC Form 4.
$413k 221,952 shares
$1.86
$1.00
Angagaw Aster Director
Holding Value $59.3k 59,000 shares
Last Trade
Feb 18, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$233k 59,000 shares
$3.95
$1.00
Wurtman David F Chief Medical Officer
Holding Value $0 0 shares
Last Trade
Oct 13, 2021 Sale
No data
No data
$1.00

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up